U of M researchers finds that losartan is not effective in reducing COVID-19 lung injuries - EurekAlert

Research from the University of Minnesota found that a common blood pressure medication — losartan — is not effective in reducing lung injury in patients with COVID-19.

A study published in JAMA Network Open, from the University of Minnesota, found that a common blood pressure medication — losartan — is not effective in reducing lung injury in patients with COVID-19… [+3412 chars]

full article...